By Drug Target Review2024-08-01T12:00:46
Organoids with SMA-pathology uncovered key findings about the disease, which could be utilised to develop new therapeutic options.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-27T13:06:00Z
2023-03-02T13:57:58
Sponsored by Cell Signaling Technology
2023-03-20T13:41:33
Sponsored by Bio-Techne
2023-04-04T15:03:09
Sponsored by Agilent
2023-03-23T14:46:21
Sponsored by Bio-Techne
2024-02-08T11:07:39
Sponsored by Samplix ApS
2024-02-01T11:52:50
Sponsored by Leica Microsystems
Site powered by Webvision Cloud